Shop Research About Compliance Affiliate Free Consultation
HOT

Cagrilintide + Semaglutide

CagriSema · Amylin + GLP-1 Dual Combination

Pre-mixed research blend of cagrilintide (amylin analog) and semaglutide (GLP-1 agonist). Studied in dual-mechanism metabolic pathway models.

✓ HPLC Verified ✓ 99%+ Purity ✓ COA Available ✓ Manufacturer Direct ✓ Direct Support
📋 Certificate of Analysis Request COA via Telegram
Select Size
per vial
+ $40 shipping · Free over $1,000 · ~2 week delivery
✓ Added to cart View Cart →
Research Data

What Is Cagrilintide + Semaglutide?

CagriSema is a fixed-ratio combination of cagrilintide (long-acting amylin receptor agonist) and semaglutide (GLP-1 receptor agonist). Research interest centers on complementary satiety and glycemic mechanisms. Phase 3 REDEFINE trials have shown ~22% body weight reduction data in clinical research.

Research Context

  • Complementary amylin + GLP-1 receptor co-activation
  • REDEFINE trial: ~22% weight reduction in clinical research
  • Satiety pathway convergence at hypothalamic level
  • Glycemic control modeling beyond GLP-1 monotherapy

Storage & Reconstitution

Store lyophilized at -20°C. Reconstitute with bacteriostatic water. Stable 28 days at 2–8°C post-reconstitution.

All products sold for research purposes only. Not for human or animal consumption. Must be 18+ to purchase. By placing an order you confirm compliance with all applicable local laws and regulations.